郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

药效评价5-HT receptors couple to activation of Akt, but not extracellular-regulated kinase (ERK), in cultured hippocampal neurons.

期刊：Journal of neurochemistry发表年份：2005作者：Daniel S Cowen; Nadine N Johnson-Farley; Tatyana Travkina
阅读更多 →

药效评价CGH2466, a combined adenosine receptor antagonist, p38 mitogen-activated protein kinase and phosphodiesterase type 4 inhibitor with potent in vitro and in vivo anti-inflammatory activities.

期刊：British journal of pharmacology发表年份：2005作者：Alexandre Trifilieff; Thomas H Keller; Neil J Press; Trevor Howe; Peter Gedeck; David Beer; Christoph Walker
阅读更多 →

药效评价Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein.

期刊：The Journal of neuroscience : the official journal of the Society for Neuroscience发表年份：2005作者：Oksana Berezovska; Alberto Lleo; Lauren D Herl; Matthew P Frosch; Edward A Stern; Brian J Bacskai; Bradley T Hyman
阅读更多 →

药效评价Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.

期刊：Journal of medicinal chemistry发表年份：2005作者：Anna Quattropani; Jérôme Dorbais; David Covini; Pierre-André Pittet; Véronique Colovray; Russell J Thomas; Richard Coxhead; Serge Halazy; Alexander Scheer; Marc Missotten; Guidon Ayala; Charles Bradshaw; Anne-Marie De Raemy-Schenk; Anthony Nichols; R
阅读更多 →